Skip to main content
. 2013 Sep 6;14(1):75. doi: 10.1186/1129-2377-14-75

Table 3.

Characteristics and cardiovascular risk factors of migraine patients and controls (n=59)

Characteristics Normal weight controls (n=15) Normal weight migraineurs (n=15) Obese controls (n=14) Obese migraineurs (n=15) p-value#
Age (years)
34.0±10.6
34.1±10.6
39.4±9.5
40.4±9.5
0.178
BMI (kg/m2)
22.2±1.7a
22.8±1.8a
34.7±4.6b
33.3±3.0b
< 0.001
Waist circumference (cm)
70.0±6.2a
73.2±6.6a
94.5±9.3b
97.0±6.7b
< 0.001
<80
14 (93.3)*
13 (86.7)*
2 (14.3)
0
< 0.001
≥80 to 87
1 (6.7)
2 (13.3)
2 (14.3)
3 (20.0)
 
≥88
0
0
10 (71.4)*
12 (80.0)*
 
Phase angle (°)
6.5±0.5
6.5±0.8
6.6±0.8
6.8±0.7
0.669
Body fat (%)
25.7±3.0a
27.7±4.0a
38.4±3.3b
37.2±3.7b
< 0.001
Body mass, lean (%)
74.2±3.0a
72.2±4.0a
61.5±3.3b
62.7±3.7b
< 0.001
Total cholesterol (mg/dL)
192.0±34.9
185.6±27.2
188.0±32.1
185.6±30.9
0.937
HDL-c (mg/dL)
54.9±11.9a
54.8±13.3a
46.7±14.0a.b
42.5±11.5b
0.022
LDL-c (mg/dL)
115.0±27.1
112.9±20.3
111.2±32.9
112.9±24.0
0.985
LDL-c, oxidized (U/L)
75.7±21.0
67.8±22.5
69.3±18.9
86.6±8.9
0.069
Triglycerides (mg/dL)
81.0 (60.0-123.0)
79.0 (57.0-120.0)
141.0 (86.2-194.7)
103.0 (79.0-223.0)
0.333
Fasting glucose (mg/dL)
81.0 (78.0-87.0)
82.0 (78.0-86.0)
86.0 (80.0-103.7)
89.0 (81.0-96.0)
0.086
Insulin, serum (μUI/mL)
7.8 (6.4-12.8)a
5.7 (4.6-10.1)a
17.7 (13.5-17.7)b
14.6 (11.8-22.2)b
< 0.001
HOMA-IR
1.5 (1.3-2.6)a
1.2 (0.9-2.0)a
3.6 (2.7-5.0)b
3.2 (2.2-4.3)b
< 0.001
Systolic BP (mmHg)
112.5 (102.5-120.0)a.b
115.0 (110.0-120.0)a
120.0 (118.7-126.2)a.b
122.5 (110.0-130.0)b
0.013
Diastolic BP (mmHg)
70.0 (70.0-70.0)a.b
72.5 (70.0-87.5)a
80.0 (80.0-85.0)b
80.0 (70.0-90.0)b
0.003
CRP (mg/L)
4.0 (4.0-4.0)
4.0 (4.0-4.0)
10.0 (4.0-12.4)
4.0 (4.0-18.1)
0.057
Framingham risk score
 
 
 
 
 
≤0.6
7 (46.7)*
6 (40.0)
1 (7.1)
1 (6.7)
0.015
>0.6
8 (53.3)
9 (60.0)
13 (92.9)
14 (93.3)*
 
Cardiovascular disease in 1st degree relative
 
 
 
 
 
Yes
5 (33.3)
5 (33.3)
6 (42.8)
1 (6.7)
0.156
No
10 (66.7)
10 (66.7)
8 (57.1)
14 (93.3)
 
Smoking status
 
 
 
 
 
Current
1 (6.7)
2 (13.3)
3 (21.4)
1 (6.7)
0.685
Past
3 (20.0)
4 (26.7)
4 (28.6)
2 (13.3)
 
Never
11 (73.3)
9 (60.0)
7 (50.0)
12 (80.0)
 
Physical activity (IPAQ)
 
 
 
 
 
Sedentary
9 (60.0)
15 (100.0)
14 (100.0)
15 (100.0)
< 0.001
Active
6 (40.0)*
0
0
0
 
Depression (BDI)
 
 
 
 
 
Absence
15 (100.0)*
6 (40.0)
9 (64.3)
7 (46.7)
0.012
Mild/moderate
0
8 (53.4)*
4 (28.6)
5 (33.3)
 
Severe
0
1 (6.6)
1 (7.1)
3 (20.0)*
 
Sleep duration (h)
 
 
 
 
 
≤ 5
0
5 (33.3)
3 (21.4)
5 (33.4)
0.092
6 to 8
14 (93.3)
10 (66.7)
9 (64.3)
7 (46.6)
 
> 8
1 (6.7)
0
2 (14.3)
3 (20.0)
 
Sleep quality (PSQI)
6.2±2.7a.b
7.2±3.5a.b
5.0±3.8a
9.6±5.0b
0.017
Good
6 (40.0)
5 (33.3)
9 (64.3)
4 (26.7)
0.188
Poor 9 (60.0) 10 (66.7) 5 (35.7) 11 (73.3)  

BDI Beck Depression Inventory, BMI body mass index, BP blood pressure, CRP C-reactive protein, HDL-c high-density lipoprotein cholesterol, HOMA-IR Insulin Resistance Homeostasis Model Assessment, IPAQ International Physical Activity Questionnaire, LDL-c low density lipoprotein cholesterol, PSQI Pittsburgh Sleep Quality Index, WC waist circumference; Framingham score – General cardiovascular disease (10-year risk) [25]. Lowest quartile used as reference category (≤0.6%).

Continuous variables expressed as mean ± standard deviation or median and interquartile range, and categorical variables, as n (%).

#p-value represents comparison among four groups with one-way ANOVA or Kruskal–Wallis test. Bold type denotes significant values (p≤0.05).

Different superscript letters represent averages/medians significantly different between groups.

*(asterisk) indicates the association found.